Tristel plc (AIM:TSTL)
London · Delayed Price · Currency is GBP · Price in GBX 370.00
+10.00 (2.78%)
Oct 31, 2025, 4:35 PM GMT+1
Tristel Market Cap
Tristel has a market cap or net worth of 176.66 million as of October 31, 2025. Its market cap has decreased by -4.32% in one year.
Market Cap
176.66M
Enterprise Value
169.70M
Revenue
46.46M
Ranking
n/a
PE Ratio
26.75
Stock Price
370.00
Market Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 176.66M, an increase of 2,457.75%. That is a compound annual growth rate of 17.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 176.66M | -12.84% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | 245.16M | 42.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |